Last reviewed · How we verify
NCT07012252
Optical Coherence Tomography of the Irido-Corneal Angle Before and After Goniotomy and Trabeculotomy in Primary Congenital Glaucoma
NA trial testing Optical coherence tomography in Optical Coherence Tomography in 32 participants. Completed in 1 November 2020.
1 November 2020
Quick facts
| Lead sponsor | Cairo University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 32 |
| Start date | 1 October 2018 |
| Primary completion | 1 November 2020 |
| Estimated completion | 1 November 2020 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Optical coherence tomography
Conditions studied
- Optical Coherence Tomography — all drugs for Optical Coherence Tomography →
- Anterior Chamber Angle — all drugs for Anterior Chamber Angle →
- Goniotomy — all drugs for Goniotomy →
- Trabeculotomy — all drugs for Trabeculotomy →
Sponsor
Cairo University
Who can join
Adults 1 Week to 72 Weeks, any sex, with Optical Coherence Tomography or Anterior Chamber Angle. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The research aimed to improve surgical techniques and long-term outcomes by utilizing this advanced imaging technology to illuminate the structural abnormalities of the anterior segment in eyes with primary congenital glaucoma.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07012252
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Optical coherence tomography
Trials testing the same drug.
- NCT07038967 — Non-Center Involving Diabetic Macular Edema Progression in Early Postoperative Period After Phacoemulsification · recruiting
- NCT05954637 — Correlation of Structure and Function in Glaucoma · completed
- NCT05817279 — AI-aided Optical Coherence Tomography for the Detection of Basal Cell Carcinoma · unknown
- NCT05517889 — Repeatability and Stability of Healthy Skin Features on OCT · completed
- NCT05335317 — Treatment of Vaginal Atrophy With Low Intensity Nanosecond Neodymium Laser · NA · recruiting
Other recruiting trials for Optical Coherence Tomography
Currently open trials in the same condition.
- NCT06040073 — Natural History of Coronary Atherosclerosis · recruiting
- NCT06520904 — Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography · Phase 4 · recruiting
- NCT06436482 — Research of Endobronchial Optical Coherence Tomography in Pre-COPD · recruiting
- NCT05340361 — Efficacy and Safety of Zotarolimus-eluting Stent Overexpansion With OCT · recruiting
- NCT05230446 — PRospective Evaluation of Complete Revascularization in Patients With multiveSsel Disease Excluding chroNic Total Occlus · NA · recruiting
Other Cairo University trials
Trials by the same sponsor.
- NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
- NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
- NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
- NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
- NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07012252 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cairo University
- Last refreshed: 10 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07012252.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing